Discover how plasma Krebs cycle intermediates could revolutionize NAFLD/MASLD diagnosis through non-invasive blood tests and mitochondrial dysfunction insights.
Discover how Dihydrotanshinone I from Salvia miltiorrhiza fights Non-Alcoholic Fatty Liver Disease by activating the IRG1 pathway
Discover how transcriptome profiling reveals the molecular dialogue between fatty liver disease and skeletal muscle dysfunction.
Explore the pathology and biopsy assessment of non-alcoholic fatty liver disease (NAFLD), now known as MASLD, including the NAS scoring system and future diagnostic technologies.